Literature DB >> 2983098

Sequence of hepatitis B virus DNA incorporated into the genome of a human hepatoma cell line.

M Ziemer, P Garcia, Y Shaul, W J Rutter.   

Abstract

Seven copies of integrated hepatitis B virus (HBV) DNA and contiguous genomic DNA from a human hepatoma cell line (PLC/PRF/5) have been isolated by molecular cloning and have been partially sequenced. The HBV sequences are fragmented and rearranged. Thus, the surface antigen gene is the only intact HBV transcription unit present in these integrated sequences. The sites of integration-recombination are dispersed over the entire viral genome; there is some preference for integration within the double-stranded portion of the genome. There are no repeats at the ends of the integrated HBV DNA fragments. Thus, recombination does not take place in a manner resembling the integration of retroviruses. The sequence data suggest that each HBV fragment is of the adw subtype. However, the integrated DNAs show an unexpected degree of sequence divergence. Direct evidence for the duplication, transposition, and subsequent divergence of two sequences is presented. The data surprisingly suggest that infection-integration of four distinct adw strains occurred.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983098      PMCID: PMC254723     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Structural and biological analysis of integrated polyoma virus DNA and its adjacent host sequences cloned from transformed rat cells.

Authors:  A Hayday; H E Ruley; M Fried
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

2.  Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

Authors:  A Fujiyama; A Miyanohara; C Nozaki; T Yoneyama; N Ohtomo; K Matsubara
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

3.  Distribution of HBsAg subtypes in the world.

Authors:  A M Couroucé-Pauty; A Plançon; J P Soulier
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

4.  Nucleotide sequence at the site of junction between adenovirus type 12 DNA and repetitive hamster cell DNA in transformed cell line CLAC1.

Authors:  S Stabel; W Doerfler
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

5.  Hepatitis B viral DNA in liver and serum of asymptomatic carriers.

Authors:  W Kam; L B Rall; E A Smuckler; R Schmid; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

6.  Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5.

Authors:  A Dejean; C Brechot; P Tiollais; S Wain-Hobson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap.

Authors:  R Koshy; S Koch; A F von Loringhoven; R Kahmann; K Murray; P H Hofschneider
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

8.  The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.

Authors:  Y Ono; H Onda; R Sasada; K Igarashi; Y Sugino; K Nishioka
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

9.  Clustered illegitimate recombination events in mammalian cells involving very short sequence homologies.

Authors:  H E Ruley; M Fried
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

10.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  G M MacNab; J J Alexander; G Lecatsas; E M Bey; J M Urbanowicz
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

View more
  27 in total

1.  Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region.

Authors:  C Shih; K Burke; M J Chou; J B Zeldis; C S Yang; C S Lee; K J Isselbacher; J R Wands; H M Goodman
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Authors:  T Tokino; S Fukushige; T Nakamura; T Nagaya; T Murotsu; K Shiga; N Aoki; K Matsubara
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Subgenomic studies on hepatitis B virus DNA integrated into the genome of hepatocellular carcinoma.

Authors:  K Togawa; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-10

4.  Integrated structures of duck hepatitis B virus DNA in hepatocellular carcinoma.

Authors:  F Imazeki; K Yaginuma; M Omata; K Okuda; M Kobayashi; K Koike
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Integrated structures of HBV DNA in chronic hepatitis and hepatoma tissues.

Authors:  S Takada; Y Gotoh; S Hayashi; M Kobayashi; K Koike
Journal:  Gastroenterol Jpn       Date:  1990-09

6.  Detection of hepatitis B virus DNA in hepatocellular carcinoma.

Authors:  J Y Chen; T J Harrison; C S Lee; D S Chen; A J Zuckerman
Journal:  Br J Exp Pathol       Date:  1986-04

7.  Integration of hepatitis B virus DNA in chromosome-specific satellite sequences.

Authors:  Y Shaul; P D Garcia; S Schonberg; W J Rutter
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

Review 8.  Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: do they indicate virus propagation? Brief review.

Authors:  O Marquardt
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 9.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

10.  Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues.

Authors:  S Takada; Y Gotoh; S Hayashi; M Yoshida; K Koike
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.